Like the most important ddr1.

Its discovery is not only a therapeutic target, but also an important marker for evaluating the prognosis of metastatic liver cancer!

If you choose to sell it, the discovery of this target alone may be able to sell hundreds of millions of yuan in many pharmaceutical companies...

Other targets are at least 100 million yuan.

Xu Qiu only spent 600 million this month, but the liver cancer target he developed can be sold at a price of at least one billion. This profit margin is enough to make any industry envious!

However, Xu Qiu could not sell this knowledge wealth...

The target for sale is hundreds of millions of yuan, and it is a one-time transaction.

And if one of the targets develops the corresponding targeted drugs, the profits will be a huge market of over 10 billion yuan per year!

This can be seen from Huining's efforts to keep his liver peaceful even though he tries his life.

Moreover, a liver peaceful lingering full of defects can still make a fortune in countries such as Daxia. Last year, Huining sold more than 100 billion yuan in global sales, and earned 30 billion yuan, of which 250 million came from liver peaceful lingering...

You should know that this is the world's second largest pharmaceutical company. It owns hundreds of drugs, but one product can earn nearly one percent of the total profit for them. It is a myth!

This is just a drug circulated privately in some countries...

If it has no flaws and is truly listed globally, it will be hard to imagine the profits it brings!

"Focus on crm17 and study it in depth along the new mechanism of angiogenesis in liver cancer." Xu Qiu gave the next step of research and development focus.

Mo Wan's face was full of shock... She originally thought ddr1 was the key point, but she didn't expect Xu Qiu to pay so much attention to this new mechanism she discovered!

When the order was transmitted to the Institute of Drug Research and Development, the three academicians, Han Chang and others were also shocked.

They also find it incredible.

From all aspects, ddr1 is based on the discovered pathogenic mechanism. Whether it is success rate, practicality, potential, etc., it is the first among the eleven targets.

However, Xu Qiu finally chose ddr1.

"Xu Qiu has great ambitions. He wants to use this new mechanism to develop an original drug that belongs entirely to him..." An academician guessed Xu Qiu's purpose.

Another academician nodded in shock: "If it is other targets, they are basically under the liver cancer mechanism that has been discovered long ago, and they all have similar alternative drugs. But if it is a new mechanism, it is equivalent to starting a new track. Even the old sorafenib, champartinib, etc. cannot compete with them!"

But the risk of doing so is very high.

There is indeed a chance to avoid competition with old magical drugs. After all, even sorafenib has only 10% to 30%. With the same mechanism, whether it is a clinician or a patient, it will choose a more suitable sorafenib without considering the price.

But if it is a brand new treatment mechanism, it may bring a huge shock to the medical community and clinical practice...

However, the difficulties are unpredictable. The difficulty and cost of R&D are at least several times that of other targets. Is five billion really enough? Can it be completed in five months?

...

...

When the New Liver Drug Research and Development Institute was in full swing, the movement of recruiting talents and seconding equipment in various parts of Daxia also alarmed countless people.

Xiaojiko, Eisai Co., Ltd.

Kuravatinib, one of the first-line treatments for advanced liver cancer, was developed by Eisai Co., Ltd. It is especially suitable for the treatment of hepatocellular carcinoma that has not received systematic treatment before and cannot be removed. The price is twice that of sorafenib. Even if you are admitted to medical insurance, the price of each tablet is about 560 yuan.

"This person named Xu Qiu... actually wants to develop liver medicine?" A sneer flashed in the eyes of the chief researcher in the Eisai Drug Research and Development Institute.

There are many difficulties in the development of liver cancer drugs.

Their company's crumbartinib is a product that has "took a sword for ten years". After studying it carefully and lying in more than ten years, it has received an amazing objective response rate of 43.8%, becoming one of the most important treatment drugs for liver cancer patients.

It is rumored that Xu Qiu actually plans to spend 5 billion to complete the research and development within five months...

Even a fraction of Cangvatinib is not considered a fraction of it.

This is simply a joke!

A man with small eyes sneered: "Xu Qiu was driven crazy by liver Anning."

Another said: "He has created so many miracles in other fields that he thought that drug development does not require brains!"

"Our employees of Eisai No. 1,000,000 have only been polished with a garvatinib in ten years. If this kid from Daxia can really succeed in researching and developing it, I will go to Linhai to apologize to him in person!"

"He seems to be the candidate for the Daxia World Championship. No wonder he will finish it in five months. In five months, he will go to the World Championship..."

"It's ridiculous. If you deal with the supervision team well, start research and development in advance, and then use liver cancer drugs as entries during the World Competition, Xu Qiu really may be ranked in the top ten or even the top five, but the result is so stupid!"

"Wait, he might soon know that the difficulty of drug development is not comparable to that of modified surgery!"

The senior executives of Eisai Co., Ltd. all sneered and had already made plans to watch the fun.

...

Huining Pharmaceutical Headquarters.

As the world's second largest pharmaceutical company, Huining has many products that are easy to take on the world, such as penicillin, oleracillin, sildenafil, etc., all of which are super single products from Huining...

Liver peace was expected to become the next new favorite, but after being frustrated in the clinical trial stage and unable to pass the review of the National Medical Products Administration of the People's Republic of China, they had to turn to expand their sales to countries such as Daxia.

But despite this, Gan Anning's ability to attract money is still beyond the expectations of everyone in Huining... The 30 billion profit last year came from this product, which really shocked everyone.

However, just when Ligan Anning was planning to open a large market in Daxia, Xu Qiu suddenly emerged and took Baiyun Province to leave the market map of Ligan An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An An exaggerated Ligan An An An An An An An An An An An An An An An An exaggerated Ligan An An An An An An An An An An An An exaggerated Ligan An An An An An An An An An An exaggerated Ligan An An An An An An An An An exaggerated Ligan An An An An An An An An An exaggerated Ligan An An An An An An An An exaggerated Ligan An An An An An An An An exaggerated Ligan An An An An An An An An exaggerated Ligan An An An An An An An An exaggerated Ligan An An An An An An An exaggerated Ligan An An An An An An An An exaggerated Ligan An An An An An An An exaggerated Ligan An An An An An An An exaggerated Ligan An An An An An An An exaggerated Ligan An An An An An An An An exaggerated Ligan An An An An An An An exaggerated Ligan A...

Within a few months, the market territory became a lot of provinces.

But Huining never cared about it... Ligan Anning's low pricing and efficacy allowed him to counter the ban and sell well. Xu Qiu and Baiyunsheng would at most let Ligan Anning go from open sales to secret circulation.

However, when Xu Qiu settled in Baiyun Pharmaceutical Factory and started the research and development of new liver cancer drugs with great fanfare, Huining finally panicked!

But it didn't last long.

When they learned that Xu Qiu planned to develop a new drug within five months, they immediately breathed a sigh of relief.

Not to mention Huining, even if it is the world's largest pharmaceutical company, it is almost impossible to complete all this within half a year regardless of costs!
Chapter completed!